{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:38:35Z","timestamp":1792175915682,"version":"4.4.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:00:00Z","timestamp":1434931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0130550","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T18:29:56Z","timestamp":1434997796000},"page":"e0130550","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":63,"title":["The Efficacy and Safety of Chinese Herbal Medicine Jinlida as Add-On Medication in Type 2 Diabetes Patients Ineffectively Managed by Metformin Monotherapy: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"chictr-trc-13003159","registry":"10.18810\/chictr"}],"author":[{"given":"Fengmei","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengdong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Su","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Country and regional data on diabetes. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/diabetes\/facts\/world_figures\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/diabetes\/facts\/world_figures\/en\/<\/ext-link>. Accessed 28 November 2014."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of Diabetes among Men and Women in China","volume":"362","author":"W Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"ref3","first-page":"837","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"13","year":"1998","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","article-title":"Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association","volume":"13","author":"JS Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc14-S014","article-title":"Standards of medical care in diabetes-2014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"ref6","article-title":"China guideline for type 2 diabetes","year":"2013"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2458-13-602","article-title":"Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectables","volume":"13","author":"LN Ji","year":"2013","journal-title":"BMC Public Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.283.13.1695","article-title":"Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"283","author":"V Fonseca","year":"2000","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A Clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"P Zeitler","year":"2012","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/dc12-0453","article-title":"The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy","volume":"36","author":"P Fouqueray","year":"2013","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1142\/S0192415X12500656","article-title":"Treatment of diabetes using traditional Chinese medicine: past, present and future","volume":"40","author":"XL Tong","year":"2012","journal-title":"Am J Chin Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/dom.12051","article-title":"The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial","volume":"15","author":"XL Tong","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e56703","DOI":"10.1371\/journal.pone.0056703","article-title":"Efficacy and safety of Traditional Chinese medicine for diabetes: a double-blind, randomised, controlled trial","volume":"8","author":"L Ji","year":"2013","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1210\/jc.2013-3276","article-title":"Chinese herbal medicine Tianqi reduces progression from impaired glucose tolerance to diabetes: a double-blind, randomized, placebo-controlled, multicenter trial","volume":"99","author":"F Lian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"ref15","first-page":"605","article-title":"A study on the effect of Jinlida on blood sugar regulating hormone and islet cell function in diabetic rats","volume":"20","author":"J Pang","year":"2014","journal-title":"Chin J Basic Med Tradit Chine Med"},{"key":"ref16","first-page":"654","article-title":"The impact of Jinlida granule on the islet function and TNF-\u03b1 level in patients with type 2 diabetes, and evaluation on its efficacy and safety","volume":"19","author":"Y Zheng","year":"2013","journal-title":"Chin J Basic Med Tradit Chine Med"},{"key":"ref17","first-page":"35","article-title":"Effects of Jinlida granule combined with metformin on treatment of patients with initial type 2 diabetes","volume":"17","author":"M Guo","year":"2013","journal-title":"J Clin Med Pract"},{"key":"ref18","first-page":"591","article-title":"Evaluation on the efficacy and safety of Jinlida granule in the treatment of type 2 diabetes","volume":"13","author":"JB Li","year":"2013","journal-title":"Eval Anal Drug-Use Hospit Chin"},{"key":"ref19","article-title":"Part I: Diagnosis and classification of diabetes mellitus","year":"1999"},{"key":"ref20","first-page":"402","article-title":"The status quo of type 2 diabetes patients with blood sugar level properly controlled by taking oral hypoglycemic agents in urban areas of China","volume":"4","author":"JM Lu","year":"2012","journal-title":"Chin J Diabetes"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"D Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7326\/0003-4819-147-6-200709180-00178","article-title":"Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus","volume":"147","author":"S Bolen","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref23","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"1","author":"S Salpeter","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1753-0407.2011.00115.x","article-title":"Comprehensive risk assessments of diabetic patients from seven Asian countries: the Joint Asia Diabetes Evaluation (JADE) program","volume":"3","author":"WY So","year":"2011","journal-title":"J Diabetes"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"HW Rodbard","year":"2009","journal-title":"Endocr Pract"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"RA DeFronzo","year":"1995","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM199803263381303","article-title":"Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus","volume":"338","author":"SE Inzucchi","year":"1998","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1001\/jama.283.13.1695","article-title":"Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial","volume":"283","author":"V Fonseca","year":"2000","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2337\/dc08-1984","article-title":"The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin alone","volume":"32","author":"RA DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc11-0606","article-title":"Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial","volume":"34","author":"MA Nauck","year":"2011","journal-title":"Diabetes Care"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/dc12-0453","article-title":"The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy","volume":"36","author":"P Fouqueray","year":"2013","journal-title":"Diabetes Care"},{"key":"ref32","first-page":"351","article-title":"Jinlida granule in treatment of patients with type 2 diabetes: a randomized and double-blind clinical study","volume":"12","author":"X Zhang","year":"2013","journal-title":"Chin J Diffic Compl Case"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1142\/S0192415X1350002X","article-title":"Clinical research of traditional Chinese medical intervention on impaired glucose tolerance","volume":"41","author":"Y Gao","year":"2013","journal-title":"Am J Chin Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.phymed.2012.09.017","article-title":"The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice","volume":"20","author":"JK Prasain","year":"2012","journal-title":"Phytomedicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.fct.2013.07.077","article-title":"Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function","volume":"60","author":"K Wu","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/JME-13-0302","article-title":"Puerarin protects pancreatic \u03b2-cell survival via PI3K\/Akt signaling pathway","volume":"53","author":"Z Li","year":"2014","journal-title":"J Mol Endocrinol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/diabetes.51.6.1851","article-title":"Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component","volume":"51","author":"AS Attele","year":"2002","journal-title":"Diabetes"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1142\/S0192415X05003004","article-title":"Ginseng and diabetes","volume":"33","author":"JT Xie","year":"2005","journal-title":"Am J Chin Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0130550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T15:04:45Z","timestamp":1566918285000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0130550"}},"subtitle":[],"editor":[{"given":"Stephen L","family":"Atkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0130550","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}